Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome

The outcome of steroid-dependent or frequently relapsing nephrotic syndrome of minimal change disease (MCD), mesangial proliferative GN (MesGN), or FSGS may be poor and with major treatment toxicity. This academic, multicenter, off-on trial (ClinicalTrials.gov #NCT00981838) primarily evaluated the e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ruggenenti, Piero, Ruggiero, Barbara, Cravedi, Paolo, Vivarelli, Marina, Massella, Laura, Marasà, Maddalena, Chianca, Antonietta, Rubis, Nadia, Ene-Iordache, Bogdan, Rudnicki, Michael, Pollastro, Rosa Maria, Capasso, Giovambattista, Pisani, Antonio, Pennesi, Marco, Emma, Francesco, Remuzzi, Giuseppe
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Nephrology 2014
Materias:
Clinical Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3968490/
https://ncbi.nlm.nih.gov/pubmed/24480824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013030251
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares